Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic cancer. It works by interfering with cancer cell growth and division, helping to slow or stop the spread of cancer cells.

Nab-paclitaxel (also known as albumin-bound paclitaxel) is a chemotherapy drug that targets and kills cancer cells by preventing them from dividing. It is bound to a protein called albumin, which helps deliver the medication more effectively to cancer cells.

FOLFIRINOX is a combination chemotherapy treatment that contains multiple medications working together to fight cancer. This treatment combines different drugs that work in various ways to kill cancer cells and prevent them from growing and spreading.

Pancreatic Ductal Adenocarcinoma – A type of cancer that begins in the cells lining the ducts of the pancreas. The disease typically starts in the pancreatic ducts and can gradually spread to nearby tissues. In its borderline resectable form, the tumor has limited involvement with nearby blood vessels but may still be surgically removable. The condition often develops slowly at first, potentially affecting the pancreas’s ability to produce digestive enzymes and hormones. As the disease progresses, it can affect surrounding tissues and organs.

Borderline Resectable Pancreatic Cancer – A specific classification of pancreatic cancer where the tumor shows limited involvement with nearby blood vessels. This condition represents an intermediate stage between clearly resectable and unresectable pancreatic cancer. The tumor touches or wraps around nearby blood vessels but does so in a way that might still allow for surgical removal. The disease affects the pancreas and its immediate surrounding structures.